mesalamine has been researched along with Synovioma in 2 studies
Mesalamine: An anti-inflammatory agent, structurally related to the SALICYLATES, which is active in INFLAMMATORY BOWEL DISEASE. It is considered to be the active moiety of SULPHASALAZINE. (From Martindale, The Extra Pharmacopoeia, 30th ed)
mesalamine : A monohydroxybenzoic acid that is salicylic acid substituted by an amino group at the 5-position.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| López-Iñiguez, A | 1 |
| Pérez-Gutiérrez, MT | 1 |
| Lambraño-Castillo, D | 1 |
| Sierra-Madero, JG | 1 |
| Omoteyama, K | 1 |
| Sato, T | 1 |
| Arito, M | 1 |
| Sato, M | 1 |
| Suematsu, N | 1 |
| Kurokawa, MS | 1 |
| Kato, T | 1 |
2 other studies available for mesalamine and Synovioma
| Article | Year |
|---|---|
Necrotic lesion in an immunosuppressed patient.
Topics: Aged; Colitis, Ulcerative; Ecthyma; Fatal Outcome; Gangrene; Humans; Immunocompromised Host; Immunos | 2018 |
Effects of salazosulfapyridine on the profile of cell surface proteins, revealed by biotinylation of cell surface proteins and 2-dimentional electrophoresis.
Topics: Biotinylation; Cell Line, Tumor; Humans; Membrane Proteins; Mesalamine; Sarcoma, Synovial; Sulfapyri | 2019 |